Novartis AG (JOBS) Lung Drug Beneficial in Late Stage Study Published: Sep 16, 2009 Reuters -- Swiss drugmaker Novartis said a respiratory medicine improved lung function and significantly reduced breathlessness in a late stage trial. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news